Robert Coutts
Finanzdirektor/CFO bei ACHILLES THERAPEUTICS PLC
Vermögen: 155 201 $ am 30.06.2024
Ursprung des Netzwerks ersten Grades von Robert Coutts
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 17 | |
| Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 10 | |
KPMG Audit Plc
 KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services KPMG Audit Plc provides accounting services. The company was founded in 1995 and is headquartered in London, GB.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robert Coutts
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman Director/Board Member Chief Executive Officer Founder Founder Founder Director/Board Member Founder | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
| University College London | College/University | Founder Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| The Syncona Foundation | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Director/Board Member Private Equity Investor | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science. | Investment Managers | Chairman Head-Equity Investments | |
| University of Bristol | College/University | Undergraduate Degree Graduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Culross Global Management Ltd.
 Culross Global Management Ltd. Investment ManagersFinance Culross Global Management Ltd. (Culross Global) is an alternative investment manager headquartered in London, UK. The firm was founded by Nigel G. Blanshard in 1992 and is a subsidiary of Culross Global Holdings Ltd. in Malta. Culross Global serves a diversified investor base of institutional and qualifying high net worth investors, for whom they manage a range of funds, bespoke portfolios and wealth management solutions with tailored risk and return objectives. | Investment Managers | Analyst-Equity | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Hyde Capital Partners Ltd. | Founder | ||
| ODYSSEAN INVESTMENT TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
| Weill Cornell Medicine | College/University | Corporate Officer/Principal | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oncovalent Therapeutics, Inc.
 Oncovalent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncovalent Therapeutics, Inc. develops immuno oncology drugs and therapeutics. The company is based in Thousand Oaks, CA. Pete Feldman has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman | |
National Institute for Bioprocessing Research & Training
 National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Biotechnology | Director/Board Member | |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Biotechnology | Corporate Officer/Principal | |
Advancion Corp.
 Advancion Corp. Chemicals: SpecialtyProcess Industries Advancion develops and delivers distinct nitro alkane and derivatives. Its markets include paints and coatings, metalworking fluids, water treatment, personal care, life sciences, wood adhesives, leather tanning, synthesis, and synthetic rubber. The company was founded in 1936 and is headquartered in Buffalo Grove, IL. | Chemicals: Specialty | Director/Board Member | |
| University College Dublin | College/University | Masters Business Admin | |
Institute of Directors In Ireland
 Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ILC Dover LP
 ILC Dover LP Pharmaceuticals: MajorHealth Technology ILC Dover LP operates as an engineering development and manufacturing company, which specializes in the use of flexible materials, serving the aerospace, personal protection, and pharmaceutical industries. Its products include lighter-than-air structures, personal protection equipment, engineered inflatables, powder containment, industrial containment, space suites, space inflatables, and specialty materials. The company was founded in 1947 and is headquartered in Federica, DE. | Pharmaceuticals: Major | Director/Board Member | |
| ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Director/Board Member | |
American Chamber of Commerce Ireland
 American Chamber of Commerce Ireland Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce Ireland is a leading international business organization that supports the Transatlantic business relationship. The non-profit company is based in Dublin, Ireland. The Irish company provides networking opportunities, leadership development programs, and representation to government, media, and stakeholders. The company's highly sought-after programs operate virtually and in person, supporting individual growth within their member companies. The CEO of the company is Mark Redmond. | Miscellaneous Commercial Services | Director/Board Member | |
Alexion Pharma International Operations Ltd.
 Alexion Pharma International Operations Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma International Operations Ltd. wholesales drugs, proprietaries and sundries. The company is based in Dublin, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| Gilead Sciences Ireland UC | Chief Operating Officer | ||
| Trinity College Dublin | College/University | Undergraduate Degree | |
| University College Cork | College/University | Corporate Officer/Principal | |
| National Standards Authority of Ireland | Chairman | ||
| AFFIMED N.V. | Biotechnology | Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LANCASHIRE HOLDINGS LIMITED | Property/Casualty Insurance | Chairman | |
Downs Syndrome Diamond Foundation Ltd.
 Downs Syndrome Diamond Foundation Ltd. Services to the Health IndustryHealth Services Downs Syndrome Diamond Foundation Ltd. is a charity organization that offers support and advice to families raising children with Down syndrome. The British company was founded in 1996 by Jeremy Barnes and Veronique Garrett. | Services to the Health Industry | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 16 |
| Vereinigte Staaten | 15 |
| Irland | 11 |
| Deutschland | 8 |
| Dänemark | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Finance | 5 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 168 |
| Chairman | 53 |
| Corporate Officer/Principal | 51 |
| Independent Dir/Board Member | 43 |
| Founder | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jonathan Moulton | 76 |
| Edwin Moses | 35 |
| Kin Wah Yiu | 20 |
| Nigel Keen | 19 |
| Derek DiRocco | 17 |
| Bernhard R. M. Ehmer | 16 |
| Julie O'Neill | 16 |
| Carsten Boess | 15 |
| Colin C. Maltby | 15 |
| Ellen Strahlman | 14 |
| Mark Lowdell | 12 |
| Peter Hames | 12 |
| Martin Nicholas Caleb Thomas | 11 |
| Iraj Ali | 10 |
| Michael Giordano | 9 |
- Börse
- Insiders
- Robert Coutts
- Unternehmensverbindungen
